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intervention measures like quitting smoking would play a key role
in preventing MI in young adults.
Intravascular ultrasound assessment
of non-culprit coronary arteries in
patients suffering from ST elevation
myocardial infarction
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Background: Our present knowledge and guidelines direct us only
to intervene on infarct related artery in STEMI patients during
Primary PCI. But vulnerable plaques do coexist in other coronaries
and can lead to fatal cardiac events in future.We took up this study
to know the actual prevalence of plaques, including their char-
acteristics & compositions in the non-infarct arteries.
Materials and methods: Forty patients undergoing PCI following
STEMI, underwent virtual histology-intravascular ultrasound (VH-
IVUS) study in proximal 10 mmsegments of the non-infarct related
arteries (non-IRA), excluding non-dominant RCA. Prevalence of
plaques and plaque composition was assessed and statistically
analyzed.
Results: A total of 37 plaques in non-infarct arteries were detected
in 34 patients among the study population. Three patients had
plaques in both the non-IRA vessels. Out of these 18 plaques were
present in LAD among which 10 were vulnerable plaques. Twelve
plaques were found in RCA comprising of 5 vulnerable plaques.
Only 7 plaqueswere found in non-infarcted LCX, out ofwhich there
were 2 vulnerable plaques. Among the IVUS parameters mean
plaque volume was 57.8 mm3. Major contribution in plaque
volume was from ﬁbrous tissue, which constituted 58.6%. Rest
was 19.7% ﬁbro-fatty tissue and necrotic core was quite prevalent
with a mean proportion of 12.9%. Proportion of calciﬁc plaque was
8.7%.
Conclusion: Patients presenting with STEMI actually have variable
number of stable and vulnerable plaques in non-infarct arteries.
LAD is most common artery to harbor non-IRA plaques. Cardio-
vascular risk factors are more prevalent in patients with non-IRA
plaques, although not statistically signiﬁcant.
Study on clinical, biochemical and
angiographic profile of young patients
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Background: Coronary artery disease particularly acute myocar-
dial infarction in young generations is fast growing due to
change in demographic proﬁle, economic status and life style
inversion. They are an important group to examine with regard
to risk factor modiﬁcation and secondary prevention. AMI in
young patients has different characteristics from that in older in
many ways, as risk factors, clinical proﬁle, presentation pat-
terns, complications, biochemical parameters, and angiography
proﬁle.
Materials and methods: 25 young patients aged below 40 years,
presenting with acute myocardial infarction, admitted in cardiol-
ogyward or ICCU inMedical college and hospital, Kolkata in 2014 (1
year) were made part of this study.
Results: Average age of the patients was 38 years. 80% were male.
Average time of presentation was 27 h with only 20% of the
patients coming within 12 h and 40% getting thrombolysis. Aver-
age BMI of the patients was 23 kg/m2. 78% patients were smokers,
65% were hypertensive, 30% were diabetic, 35% were dyslipidemic
and 32% having all these 4 risk factors. Average presenting blood
pressure was 145/90 and pulse 102/min. 45% patients had anterior
wall myocardial infarction, 30% inferior wall MI and 25 having
NSTEMI. Average ejection fractionwas 42with 32%patients having
EF less than 40. In coronary angiography 2 out of 25 patients (8%)
had almost normal coronaries, 52% had signiﬁcant LAD lesion, 28%
had signiﬁcant RCA stenosis and 20% had LCX lesion. 8% patients
had left main coronary artery lesion, 8% had 2 vessel disease and
4% had 3 vessel disease.
Conclusion: This study shows detailed characteristics of young
patients presenting with AMI, including risk factors, clinical pre-
sentations, biochemical parameters, angiographic proﬁle and
helps to understand the whole spectrum, which is different from
their older-age counter-part and reiterates the need of establishing
thorough system for early recognition, prevention and awareness
of CAD among young generations in India.
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Background: Cardiovascular diseases (CVD) are the leading cause
of death in theWorld (31% of all deaths) andMongolia as well. CVD
has been the leading cause of death in Mongolia for the last 20
years and consists one of 3 death cases. In its turn 59.6% of CVD
mortality caused by ischemic heart diseases.
When the coronary atherosclerotic plaque becomes vulnerable, a
thrombus develops on that ruptured plaque and then occludes the
coronary artery, which causes acute blood deﬁciency in the down-
stream myocardium. Some studies indicate that matrix metallo-
proteinase-9 (MMP-9) plays a key role on pathogenesis of plaque
rupture.
Objectives: To study the involvement of serum MMP-9 enzyme in
the pathogenesis during the rupture of the coronary atherosclero-
sis plaque.
Methods: The study was conducted using case–control design. The
main inclusion criteria of the case group is that the patient should
have a ruptured coronary atherosclerotic plaque, conﬁrmed by
clinical sign, ECG, troponin I, angiography. The total number of
patients is 80, half of them belongs to the case group. MMP-9 was
determined in serum by ELISA. We used CIIS (cardiac infarction
injury score) by ECG and Gensini score system (coronary angio-
graphic scoring system) for assessing the severity of coronary heart
disease.
Results: The average level of MMP-9 in case and control groups is
0.396  0.155 ng/ml, 0.223  0.087 ng/ml respectively with
p < 0.001 signiﬁcance which shows MMP-9 (OR = 0.001, p < 0.001)
may play a role in the pathogenesis of plaque rupture. MMP-9 is
correlatedwith Gensini score and CIIS score, respectively (r = 0.552,
p < 0.01; r = 0.340, p < 0.01) which shows MMP-9 is being elevated
with the increase of the severity of coronary heart disease and the
cardiac infarction injury.
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Serum MMP-9 increases statistically signiﬁcantly ( p < 0.001) with
the increase of the severity of the stenosis and the number of the
affected arteries: no severe stenosis (<75% stenosis) (0.245
 0.086 ng/ml); 1 vessel severe (>75%) stenosis (0.317  0.132 ng/
ml), 2 vessel severe stenosis (0.348  0.157 ng/ml), 3 vessel severe
stenosis (0.422  0.112 ng/ml).
Furthermore, serum MMP-9 enzyme increases with accordance of
severity of the myocardium injury with the statistical signiﬁcance
( p < 0.01): the borderline abnormality group (CIIS < 10, 0.227
 0.099 ng/ml), possible injury (CIIS 10–15, 0.317  0.132 ng/ml),
probable injury (CIIS > 15, 0.376  0.132 ng/ml) group. MMP-9
levels were signiﬁcantly higher in the probable injury (CIIS >15)
patients compared to the possible injury (CIIS 10–15) patients
( p < 0.001).
Conclusion: An increase in serum MMP-9 enzyme levels is a risk
factor of the coronary atherosclerotic plaque rupture (OR = 0.001,
p < 0.001).
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Background:Cardiovascular disease (CVD) is an important cause of
mortality andmorbidity in India. Mortality statistics andmorbidity
surveys indicate substantial regional variations in CVD prevalence
and mortality rates. WHO has predicted that from years 2000 to
2020 disability-adjusted life years lost from coronary heart disease
in India shall double in both men and women from 7.7 and 5.5
million, respectively. This health scenario will therefore demand a
robust healthcare infrastructure and integrated approach of CVD
prevention and management.
Aim: To study impact on patient & procedure outcomes of Cath lab
by monitoring of Cath lab quality indicators.
Objectives: (a) Tomaintain a dedicated database of Cath lab quality
indicators (CQI) as a continuous improvement initiative. (b) Bench-
marking Cath lab procedural outcomes against current standards
of Cath lab quality for future improvisation.
Methodology: This study was carried out from February 2013 to
February 2015& involved 2000 cases. 3 duration groups of 8months
eachwere consideredwith 650, 800, 550 patients in 1st eightmonth
group, 800 patients in 2nd eight month group & 550 patients in 3rd
eight month group respectively.
Inclusion criteria: Patients above 18 years of age, admitted for diag-
nostic coronary angiograms and/or PCI procedures who have given
written informed consent for above procedures.
Exclusion criteria: Post-operative CABG patients, Patients studied for
non-coronary issues, such as pulmonary hypertension, cardio-
myopathy, valvular disease, or adult congenital heart disease
who did not undergo PCI.
Data collection technique & tools: Documentation of Cath lab quality
indicatorswasdoneonbasisofGUIDELINESas laiddownby ‘‘Quality
Assessment and Improvement in Interventional Cardiology: 2011
Statement of the Society of Cardiovascular Angiography and Inter-
vention (SCAI) & 2012 ACCF & SCAI Expert Consensus Document on
Cardiac Catheterization Laboratory Standards Update.
Salient results: (a) The mean door-to-balloon time (DTB) improved
signiﬁcantly from 84 min in 1st group to 79 min in 2nd group to
73 min in last group. The average DTB in all the 3 groups were
found to be well within the recommended timeframe of 90 min as
per AHA guidelines.
(b) For the patients who underwent elective PCI or PAMI, 75.2% of
the procedures done were appropriately indicated as per the
appropriate use criteria of AHA. 23.5% of the PCI procedures were
moderately appropriate & only 1.3% of the procedures performed
had rarely appropriate indications. Also a positive trend was noted
for use of appropriate indications from 1st group towards the last
group. On the other hand, use of rarely appropriate indication for
PCI showed statistically signiﬁcant decline from 1.6% to 1.3% to
1.1% from 1st to 3rd group respectively; reﬂecting the trend
towards guideline-based practice.
(c) Access site complications showed a declining trend with 26 com-
plications in1stgroup, 10complications in2ndgroup&4 in lastgroup.
(d) Amongst other vascular complications, a total, 0.2% of abrupt
coronary vessel closurewith slowﬂow, 0.4% coronary perforations,
0.8% coronary dissections, 0.5% cardiac tamponade were noted
with declining trend from 1st group to 3rd group.
(e) Re-infarctions were noted as 0.3% on-table, 1% during hospital
stay. Only 1 case of subacute stent thrombosis was seen & no cases
requiring emergency CABG were seen during study period. There
were 0.3% (5) cases of pulmonary edema, 0.2% (4) cases of stroke
but none of them observed in 3rd eight month group. Morbidity
owing to above complications in our study is well within the
standard reported data.
(f)Overall incidenceofdeathwasnoted as (0.00%)on table, (0.10%) in
hospital & (0.05%) after 30 dayswith all of these events encountered
in primary PCI (PAMI) cases while the survival rate was overall
99.85%. Considering the American heart association guidelines on
mortality to be below 1% for CAG <2% for PTCA, <5% for PAMI,
observations in above study are in accordance with the guidelines.
(g) The use of mean contrast volume & Radiation was in accor-
dance with the ‘‘ALARA’’ principle (as low as reasonably achiev-
able) of AHA and the recent SIR (Society of Interventional
Radiology) guidelines reﬂecting institutional trend towards prac-
tising safety standards for Radiation.
Conclusions: This study has allowed collection of data pertaining
2000 patients undergoing coronary angiography and/or angio-
plasty, analysis of their demographic, epidemiologic, clinical vari-
ables with comparison amongst 3 duration-based groups & also
contemporary international studies & the ACC/AHA guidelines
revealing mortality & morbidity parameters as well within the
framework of standard guidelines. It thus reﬂects upon use of
standard practices in Interventional cardiovascular care, culmi-
nating into favorable patient outcomes. The study has shown a
positive impact on patient & procedure outcomes bymonitoring of
Cath lab quality indicators. It has helped establish a continuous
care initiative in Cath lab by maintaining a dedicated database of
Cath lab quality indicators allowing for future benchmarking of
procedural outcomes against standard practices in cardiovascular
care thus achieving all aims and objectives it had set out with. The
study emphatically recommends monitoring of Cath lab quality
indicators as a routine practice in Cath labs everywhere. Inputs
from cardiac catheterization laboratories from all around our
country into a common National Registry will go a long way in
assessing current trends in patient presentation, patient manage-
ment, improve patient outcomes, also help modulate cardiovas-
cular guidelines as per national scenario, aid in formulating newer
benchmarks and probably contribute to the next wave of evolution
in Interventional cardiology.
Efficiency and safety of thrombolysis
with tenecteplase in acute ST elevation
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Background: Thrombolysis in ST elevationMI (STEMI) continues to
be life savingmeans of reperfusion therapy in our country specially
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